J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers et al., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, vol.136, pp.359-386, 2015.

C. A. Gonzalez and E. Riboli, Diet and cancer prevention: Contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study, Eur J Cancer, vol.46, pp.2555-2562, 2010.

E. R. Fearon and B. Vogelstein, A genetic model for colorectal tumorigenesis, Cell, vol.61, pp.759-767, 1990.

V. Deschoolmeester, M. Baay, P. Specenier, F. Lardon, and J. B. Vermorken, A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy, Oncologist, vol.15, pp.699-731, 2010.

S. D. Markowitz and M. M. Bertagnolli, Molecular origins of cancer: Molecular basis of colorectal cancer, N Engl J Med, vol.361, pp.2449-2460, 2009.

H. T. Lynch and J. F. Lynch, Genetics of colonic cancer, Digestion, vol.59, pp.481-492, 1998.

M. Toyota, N. Ahuja, M. Ohe-toyota, J. G. Herman, S. B. Baylin et al., CpG island methylator phenotype in colorectal cancer, Proc Natl Acad Sci, vol.96, pp.8681-8686, 1999.

J. Guinney, R. Dienstmann, X. Wang, A. De-reyniès, A. Schlicker et al., The consensus molecular subtypes of colorectal cancer, Nat Med, vol.21, pp.1350-1356, 2015.

H. Clevers and R. Nusse, Wnt/?-catenin signaling and disease, Cell, vol.149, pp.1192-1205, 2012.

D. J. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schütz et al., The nuclear receptor superfamily: the second decade, Cell, vol.83, pp.835-839, 1995.

X. Xiao, P. Wang, and K. C. Chou, Recent progresses in identifying nuclear receptors and their families, Curr Top Med Chem, vol.13, pp.1192-1200, 2013.

P. Germain, B. Staels, C. Dacquet, M. Spedding, and V. Laudet, Overview of nomenclature of nuclear receptors, Pharmacol Rev, vol.58, pp.685-704, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00187929

D. L. Bain, A. F. Heneghan, K. D. Connaghan-jones, and M. T. Miura, Nuclear receptor structure: implications for function, Annu Rev Physiol, vol.69, pp.201-220, 2007.

P. J. Kushner, D. A. Agard, G. L. Greene, T. S. Scanlan, A. K. Shiau et al., Estrogen receptor pathways to AP-1, J Steroid Biochem Mol Biol, vol.74, pp.311-317, 2000.

C. Berger, Y. Qian, and X. Chen, The p53-estrogen receptor loop in cancer, Curr Mol Med, vol.13, pp.1229-1240, 2013.

S. Safe, Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions, Vitam Horm, vol.62, pp.231-252, 2001.

L. Sas, F. Lardon, P. B. Vermeulen, J. Hauspy, P. Van-dam et al., The interaction between ER and NF?B in resistance to endocrine therapy, Breast Cancer Res, vol.14, p.212, 2012.

D. J. Mulholland, S. Dedhar, G. A. Coetzee, and C. C. Nelson, Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?, Endocr Rev, vol.26, pp.898-915, 2005.

S. Modica, F. Gofflot, S. Murzilli, D. 'orazio, A. Salvatore et al., The intestinal nuclear receptor signature with epithelial localization patterns and expression modulation in tumors, Gastroenterology, vol.138, pp.636-648, 2010.

I. D'errico and A. Moschetta, Nuclear receptors, intestinal architecture and colon cancer: an intriguing link, Cell Mol Life Sci, vol.65, pp.1523-1543, 2008.

O. Wada-hiraike, O. Imamov, H. Hiraike, K. Hultenby, T. Schwend et al., Role of estrogen receptor beta in colonic epithelium, Proc Natl Acad Sci, vol.103, pp.2959-2964, 2006.

E. Kallay, P. Pietschmann, S. Toyokuni, E. Bajna, P. Hahn et al., Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage, Carcinogenesis, vol.22, pp.1429-1435, 2001.

C. Y. Logan and R. Nusse, The Wnt signaling pathway in development and disease, Annu Rev Cell Dev Biol, vol.20, pp.781-810, 2004.

O. A. Botrugno, E. Fayard, J. S. Annicotte, C. Haby, T. Brennan et al., Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation, Mol Cell, vol.15, pp.499-509, 2004.

H. G. Pálmer, J. M. González-sancho, J. Espada, M. T. Berciano, I. Puig et al., Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling, J Cell Biol, vol.154, pp.369-387, 2001.

V. Easwaran, M. Pishvaian, . Salimuddin, and S. Byers, Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways, Curr Biol, vol.9, pp.1415-1418, 1999.

D. R. Chesire and W. B. Isaacs, Ligand-dependent inhibition of betacatenin/TCF signaling by androgen receptor, Oncogene, vol.21, pp.8453-8469, 2002.

T. C. He, T. A. Chan, B. Vogelstein, and K. W. Kinzler, PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs, Cell, vol.99, pp.335-345, 1999.

R. A. Gupta, J. Tan, W. F. Krause, M. W. Geraci, T. M. Willson et al., Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer, Proc Natl Acad Sci, vol.97, pp.13275-13280, 2000.

K. L. Vandussen, A. J. Carulli, T. M. Keeley, S. R. Patel, B. J. Puthoff et al., Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells, Development, vol.139, pp.488-497, 2012.

G. Peignon, A. Durand, W. Cacheux, O. Ayrault, B. Terris et al., Complex interplay between ?-catenin signalling and Notch effectors in intestinal tumorigenesis, Gut, vol.60, pp.166-176, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00553865

E. Kress, A. Rezza, J. Nadjar, J. Samarut, and M. Plateroti, The frizzledrelated sFRP2 gene is a target of thyroid hormone receptor alpha1 and activates beta-catenin signaling in mouse intestine, J Biol Chem, vol.284, pp.1234-1241, 2009.

M. Sirakov, A. Boussouar, E. Kress, C. Frau, I. N. Lone et al., The thyroid hormone nuclear receptor TR?1 controls the Notch signaling pathway and cell fate in murine intestine, Development, vol.142, pp.2764-2774, 2015.

S. A. Oñate, S. Y. Tsai, M. J. Tsai, O. Malley, and B. W. , Sequence and characterization of a coactivator for the steroid hormone receptor superfamily, Science, vol.270, pp.1354-1357, 1995.

J. Xu, R. C. Wu, O. Malley, and B. W. , Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family, Nat Rev Cancer, vol.9, pp.615-630, 2009.

Y. Zhu, C. Qi, C. Calandra, M. S. Rao, and J. K. Reddy, Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor gamma, Gene Expr, vol.6, pp.185-195, 1996.

C. Fonte, J. Grenier, A. Trousson, A. Chauchereau, O. Lahuna et al., Involvement of {beta}-catenin and unusual behavior of CBP and p300 in glucocorticosteroid signaling in Schwann cells, Proc Natl Acad Sci, vol.102, pp.14260-14265, 2005.
URL : https://hal.archives-ouvertes.fr/hal-01939762

H. Li, J. H. Kim, S. S. Koh, and M. R. Stallcup, Synergistic effects of coactivators GRIP1 and beta-catenin on gene activation: cross-talk between androgen receptor and Wnt signaling pathways, J Biol Chem, vol.279, pp.4212-4220, 2004.

Z. Tong, M. Li, W. Wang, P. Mo, L. Yu et al., Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/ ?-Catenin Signaling, J Biol Chem, vol.290, pp.18596-18608, 2015.

S. S. Koh, D. Chen, Y. H. Lee, and M. R. Stallcup, Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities, J Biol Chem, vol.276, pp.1089-1098, 2001.

S. Jain, S. Pulikuri, Y. Zhu, C. Qi, Y. S. Kanwar et al., Differential expression of the peroxisome proliferatoractivated receptor gamma (PPARgamma) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse, Am J Pathol, vol.153, pp.349-354, 1998.

C. Chen, Y. Lu, J. Liu, L. Li, N. Zhao et al., Genome-wide ChIP-seq analysis of TCF4 binding regions in colorectal cancer cells, Int J Clin Exp Med, vol.7, pp.4253-4259, 2014.

J. J. Voegel, M. J. Heine, C. Zechel, P. Chambon, and H. Gronemeyer, TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors, EMBO J, vol.15, pp.3667-3675, 1996.

A. Mukherjee, S. M. Soyal, R. Fernandez-valdivia, M. Gehin, P. Chambon et al., Steroid receptor coactivator 2 is critical for progesterone-dependent uterine function and mammary morphogenesis in the mouse, Mol Cell Biol, vol.26, pp.6571-6583, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00188068

F. Picard, M. Géhin, J. Annicotte, S. Rocchi, M. F. Champy et al., SRC-1 and TIF2 control energy balance between white and brown adipose tissues, Cell, vol.111, pp.931-941, 2002.

J. Torchia, D. W. Rose, J. Inostroza, Y. Kamei, S. Westin et al., The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function, Nature, vol.387, pp.677-684, 1997.

R. Giannini and A. Cavallini, Expression analysis of a subset of coregulators and three nuclear receptors in human colorectal carcinoma, Anticancer Res, vol.25, pp.4287-4292, 2005.

P. D. Grivas, V. Tzelepi, G. Sotiropoulou-bonikou, Z. Kefalopoulou, A. G. Papavassiliou et al., Estrogen receptor alpha/beta, AIB1, and TIF2 in colorectal carcinogenesis: do coregulators have prognostic significance?, Int J Colorectal Dis, vol.24, pp.613-622, 2009.

J. Yu, W. K. Wu, Q. Liang, N. Zhang, J. He et al., Disruption of NCOA2 by recurrent fusion with LACTB2 in colorectal cancer, Oncogene, vol.35, pp.187-195, 2016.

L. N. Song and E. P. Gelmann, Interaction of beta-catenin and TIF2/ GRIP1 in transcriptional activation by the androgen receptor, J Biol Chem, vol.280, pp.37853-37867, 2005.

S. L. Anzick, J. Kononen, R. L. Walker, D. O. Azorsa, M. M. Tanner et al., AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer, Science, vol.277, pp.965-968, 1997.

D. E. Aust, M. Muders, A. Köhler, M. Schmidt, J. Diebold et al., Prognostic relevance of 20q13 gains in sporadic colorectal cancers: a FISH analysis

, Scand J Gastroenterol, vol.39, pp.766-772, 2004.

D. Xie, J. S. Sham, W. F. Zeng, H. L. Lin, J. Bi et al., Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma, Hum Pathol, vol.36, pp.777-783, 2005.

C. Sakakura, A. Hagiwara, R. Yasuoka, Y. Fujita, M. Nakanishi et al., Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers, Int J Cancer, vol.89, pp.217-223, 2000.

P. Mo, Q. Zhou, L. Guan, Y. Wang, W. Wang et al., Amplified in breast cancer 1 promotes colorectal cancer progression through enhancing notch signaling, Oncogene, vol.34, pp.3935-3945, 2015.

M. A. Mahajan and H. H. Samuels, Nuclear hormone receptor coregulator: role in hormone action, metabolism, growth, and development, Endocr Rev, vol.26, pp.583-597, 2005.

S. K. Lee, S. L. Anzick, J. E. Choi, L. Bubendorf, X. Y. Guan et al., A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for liganddependent transactivation by nuclear receptors in vivo, J Biol Chem, vol.274, pp.34283-34293, 1999.

M. A. Mahajan, A. Murray, D. Levy, and H. H. Samuels, Nuclear receptor coregulator (NRC): mapping of the dimerization domain, activation of p53 and STAT-2, and identification of the activation domain AD2 necessary for nuclear receptor signaling, Mol Endocrinol, vol.21, pp.1822-1834, 2007.

D. P. Kelly and R. C. Scarpulla, Transcriptional regulatory circuits controlling mitochondrial biogenesis and function, Genes Dev, vol.18, pp.357-368, 2004.

P. Puigserver, Z. Wu, C. W. Park, R. Graves, M. Wright et al., A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis, Cell, vol.92, pp.829-839, 1998.

S. Modica, S. Murzilli, L. Salvatore, D. R. Schmidt, and A. Moschetta, Nuclear bile acid receptor FXR protects against intestinal tumorigenesis, Cancer Res, vol.68, pp.9589-9594, 2008.

J. H. Xiao, C. Ghosn, C. Hinchman, C. Forbes, J. Wang et al., Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway, J Biol Chem, vol.278, pp.29954-29962, 2003.

I. D'errico, S. L. Murzilli, S. , L. Sasso, G. Latorre et al., Peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC1alpha) is a metabolic regulator of intestinal epithelial cell fate, Proc Natl Acad Sci, vol.108, pp.6603-6608, 2011.

Z. Arany, W. R. Sellers, D. M. Livingston, and R. Eckner, E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators, Cell, vol.77, pp.799-800, 1994.

V. V. Ogryzko, R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani, The transcriptional coactivators p300 and CBP are histone acetyltransferases, Cell, vol.87, pp.953-959, 1996.

N. Shikama, C. W. Lee, S. France, L. Delavaine, J. Lyon et al., A novel cofactor for p300 that regulates the p53 response, Mol Cell, vol.4, pp.365-376, 1999.

M. Muraoka, M. Konishi, R. Kikuchi-yanoshita, K. Tanaka, N. Shitara et al., p300 gene alterations in colorectal and gastric carcinomas, Oncogene, vol.12, pp.1565-1569, 1996.

N. G. Iyer, S. F. Chin, H. Ozdag, Y. Daigo, D. E. Hu et al., p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels, Proc Natl Acad Sci, vol.101, pp.7386-7391, 2004.

J. W. Huh, H. C. Kim, S. H. Kim, Y. A. Park, Y. B. Cho et al., Prognostic impact of p300 expression in patients with colorectal cancer, J Surg, vol.108, pp.374-377, 2013.

K. Ishihama, M. Yamakawa, S. Semba, H. Takeda, S. Kawata et al., Expression of HDAC1 and CBP/p300 in human colorectal carcinomas, J Clin Pathol, vol.60, pp.1205-1210, 2007.

T. Miyabayashi, J. L. Teo, M. Yamamoto, M. Mcmillan, C. Nguyen et al., Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency, Proc Natl Acad Sci, vol.104, pp.5668-5673, 2007.

K. I. Takemaru and R. T. Moon, The transcriptional coactivator CBP interacts with beta-catenin to activate gene expression, J Cell Biol, vol.149, pp.249-254, 2000.

M. Bordonaro and D. L. Lazarova, CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer, World J Gastroenterol, vol.21, pp.8238-8248, 2015.

K. H. Emami, C. Nguyen, H. Ma, D. H. Kim, K. W. Jeong et al., A small molecule inhibitor of beta-catenin/CREB-binding protein transcription

, Proc Natl Acad Sci, vol.101, pp.12682-12687, 2004.

H. Ma, C. Nguyen, K. S. Lee, and M. Kahn, Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression, Oncogene, vol.24, pp.3619-3631, 2005.

C. X. Yuan, M. Ito, J. D. Fondell, Z. Y. Fu, and R. G. Roeder, The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion, Proc Natl Acad Sci, vol.95, pp.7939-7944, 1998.

Y. Zhu, C. Qi, S. Jain, M. S. Rao, and J. K. Reddy, Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor, J Biol Chem, vol.272, pp.25500-25506, 1997.

K. A. Kwon, J. Yun, S. Y. Oh, B. G. Seo, S. Lee et al., Clinical Significance of Peroxisome Proliferator-Activated Receptor ? and TRAP220 in Patients with Operable Colorectal Cancer, Cancer Res Treat, vol.48, pp.198-207, 2016.

J. H. Howard, A. Frolov, C. W. Tzeng, A. Stewart, A. Midzak et al., Epigenetic downregulation of the DNA repair gene MED1/MBD4 in colorectal and ovarian cancer, Cancer Biol Ther, vol.8, pp.94-100, 2009.

J. D. Chen and R. M. Evans, A transcriptional co-repressor that interacts with nuclear hormone receptors, Nature, vol.377, pp.454-457, 1995.

A. J. Hörlein, A. M. Näär, T. Heinzel, J. Torchia, B. Gloss et al., Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor, Nature, vol.377, pp.397-404, 1995.

P. J. Watson, L. Fairall, and J. W. Schwabe, Nuclear hormone receptor corepressors: structure and function, Mol Cell Endocrinol, vol.348, pp.440-449, 2012.

W. Fischle, F. Dequiedt, M. J. Hendzel, M. G. Guenther, M. A. Lazar et al., Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR, Mol Cell, vol.9, pp.45-57, 2002.

C. C. Spurling, C. A. Godman, E. J. Noonan, T. P. Rasmussen, D. W. Rosenberg et al., HDAC3 overexpression and colon cancer cell proliferation and differentiation, Mol Carcinog, vol.47, pp.137-147, 2008.

A. J. Wilson, D. S. Byun, N. Popova, L. B. Murray, L. 'italien et al., Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer, J Biol Chem, vol.281, pp.13548-13558, 2006.

W. Weichert, A. Röske, S. Niesporek, A. Noske, A. C. Buckendahl et al., Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo, Clin Cancer Res, vol.14, pp.1669-1677, 2008.

V. Fernández-majada, C. Aguilera, A. Villanueva, F. Vilardell, A. Robert-moreno et al., Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer, Proc Natl Acad Sci, vol.104, pp.276-281, 2007.

J. E. Hoberg, F. Yeung, and M. W. Mayo, SMRT derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival, Mol Cell, vol.16, pp.245-255, 2004.

V. Fernández-majada, J. Pujadas, F. Vilardell, G. Capella, M. W. Mayo et al., Aberrant cytoplasmic localization of N-CoR in colorectal tumors, Cell Cycle, vol.6, pp.1748-1752, 2007.

V. Cavaillès, S. Dauvois, L. Horset, F. Lopez, G. Hoare et al., Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor, EMBO J, vol.14, pp.3741-3751, 1995.

A. Docquier, P. O. Harmand, S. Fritsch, M. Chanrion, J. M. Darbon et al., The transcriptional coregulator RIP140 represses E2F1 activity and discriminates breast cancer subtypes, Clin Cancer Res, vol.16, pp.2959-2970, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00482822

A. Castet, A. Boulahtouf, G. Versini, S. Bonnet, P. Augereau et al., Multiple domains of the Receptor-Interacting Protein 140 contribute to transcription inhibition, Nucleic Acids Res, vol.32, pp.1957-1966, 2004.

X. J. Yang and E. Seto, Lysine acetylation: codified crosstalk with other posttranslational modifications, Mol Cell, vol.31, pp.449-461, 2008.

M. Lapierre, S. Bonnet, C. Bascoul-mollevi, I. Ait-arsa, S. Jalaguier et al., RIP140 increases APC expression and controls intestinal homeostasis and tumorigenesis, J Clin Invest, vol.124, pp.1899-1913, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00972586

D. Zhang, Y. Wang, Y. Dai, J. Wang, T. Suo et al., Downregulation of RIP140 in hepatocellular carcinoma promoted the growth and migration of the cancer cells, Tumour Biol, vol.36, pp.2077-2085, 2015.

I. Fernandes, Y. Bastien, T. Wai, K. Nygard, R. Lin et al., Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms, Mol Cell, vol.11, pp.139-150, 2003.

S. Jalaguier, C. Teyssier, N. Achour, T. Lucas, A. Bonnet et al., Complex regulation of LCoR signaling in breast cancer cells, Oncogene, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02294843

M. R. Calderon, M. Verway, B. S. An, A. Difeo, T. A. Bismar et al., Ligand-dependent corepressor (LCoR) recruitment by Kruppel-like factor 6 (KLF6) regulates expression of the cyclin-dependent kinase inhibitor CDKN1A gene, J Biol Chem, vol.287, pp.8662-8674, 2012.

H. L. Reeves, G. Narla, O. Ogunbiyi, A. I. Haq, A. Katz et al., Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer, Gastroenterology, vol.126, pp.1090-1103, 2004.

R. Kumar, R. A. Wang, and R. Bagheri-yarmand, Emerging roles of MTA family members in human cancers, Semin Oncol, vol.30, pp.30-37, 2003.

N. Sen, B. Gui, and R. Kumar, Role of MTA1 in cancer progression and metastasis, Cancer Metastasis Rev, vol.33, pp.879-889, 2014.

Y. Toh, E. Oki, S. Oda, E. Tokunaga, S. Ohno et al., Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis, Int J Cancer, vol.74, pp.459-463, 1997.

T. Cagatay, S. Cimen, I. Savas, B. Banerjee, and S. , MTA-1 expression is associated with metastasis and epithelial to mesenchymal transition in colorectal cancer cells, Tumour Biol, vol.34, pp.1189-1204, 2013.